Register  /  Login               
Print this article
- 12/13/2017

FDA laid out a strategy for regulating cell-based medicine

Pharma Horizon

Tags: ,

The Food and Drug Administration has decide to crack down on doctors pushing stem cell procedures that might grave risks and therefore it will regulate cell-based medicine.

Many doctors and business  promote stem cell injections for dozens of diseases including arthritis, multiple sclerosis, and even Alzheimer’s that can cost $5,000 to $50,000, but there’s little research that such procedures are safe or effective.



Read further: Boston Globe

About us

tks | publisher, event organiser,
media agency

Viale Brianza, 22
20127 - Milano - Italy
Tel. +39 02 26809375